Molina Healthcare(US:MOH) Prnewswire·2025-07-31 22:45Core Viewpoint - Molina Healthcare, Inc. is under investigation for potential securities fraud and unlawful business practices following disappointing financial results and significant stock price declines [1][2][3]. Financial Performance - On July 7, 2025, Molina reported preliminary adjusted earnings of approximately $5.50 per share and lowered its full-year 2025 adjusted earnings guidance by over 10% to a range of $21.50 to $22.50 per share [2]. - The finalized second-quarter results on July 23, 2025, showed adjusted earnings per diluted share of $5.48, which missed both analyst consensus estimates and prior company guidance [3]. - The earnings shortfall was attributed to elevated medical cost pressures, including increased utilization of behavioral health, pharmacy, and inpatient/outpatient services [3]. Stock Price Reaction - Following the preliminary earnings announcement on July 7, 2025, Molina's stock price fell by $6.97, or approximately 2.9%, closing at $232.61 per share [2]. - After the finalized second-quarter results on July 23, 2025, the stock price dropped by $32.03, or approximately 16.8%, closing at $158.22 per share [4].